190 related articles for article (PubMed ID: 35276465)
61. Ginkgo biloba Extract in Vascular Protection: Molecular Mechanisms and Clinical Applications.
Tian J; Liu Y; Chen K
Curr Vasc Pharmacol; 2017; 15(6):532-548. PubMed ID: 28707602
[TBL] [Abstract][Full Text] [Related]
62. Isoform-selective activation of human constitutive androstane receptor by Ginkgo biloba extract: functional analysis of the SV23, SV24, and SV25 splice variants.
Lau AJ; Yang G; Chang TK
J Pharmacol Exp Ther; 2011 Nov; 339(2):704-15. PubMed ID: 21862659
[TBL] [Abstract][Full Text] [Related]
63. Discovery of unreported ginkgolides of anti-PAF activity using characteristic ion and neutral loss recognition strategy in Ginkgo biloba L.
Zhang J; Cheng J; Yan L; Yu Y; Hao C; Zhao A; Chen S; Liu A
Phytochemistry; 2022 Nov; 203():113355. PubMed ID: 35948139
[TBL] [Abstract][Full Text] [Related]
64. Liquid chromatography-atmospheric pressure chemical ionisation/mass spectrometry: a rapid and selective method for the quantitative determination of ginkgolides and bilobalide in ginkgo leaf extracts and phytopharmaceuticals.
Jensen AG; Ndjoko K; Wolfender JL; Hostettmann K; Camponovo F; Soldati F
Phytochem Anal; 2002; 13(1):31-8. PubMed ID: 11899603
[TBL] [Abstract][Full Text] [Related]
65. Human pharmacokinetics of ginkgo terpene lactones and impact of carboxylation in blood on their platelet-activating factor antagonistic activity.
Liu XW; Yang JL; Niu W; Jia WW; Olaleye OE; Wen Q; Duan XN; Huang YH; Wang FQ; Du FF; Zhong CC; Li YF; Xu F; Gao Q; Li L; Li C
Acta Pharmacol Sin; 2018 Dec; 39(12):1935-1946. PubMed ID: 30054600
[TBL] [Abstract][Full Text] [Related]
66. Ginkgo biloba leaf extract reverses amyloid beta-peptide-induced isoprostane production in rat brain in vitro.
Brunetti L; Orlando G; Menghini L; Ferrante C; Chiavaroli A; Vacca M
Planta Med; 2006 Nov; 72(14):1296-9. PubMed ID: 17022004
[TBL] [Abstract][Full Text] [Related]
67. Ginkgo biloba extract mitigates liver fibrosis and apoptosis by regulating p38 MAPK, NF-κB/IκBα, and Bcl-2/Bax signaling.
Wang Y; Wang R; Wang Y; Peng R; Wu Y; Yuan Y
Drug Des Devel Ther; 2015; 9():6303-17. PubMed ID: 26664050
[TBL] [Abstract][Full Text] [Related]
68. The effects of Ginkgo biloba on metabolic syndrome: A review.
Eisvand F; Razavi BM; Hosseinzadeh H
Phytother Res; 2020 Aug; 34(8):1798-1811. PubMed ID: 32097990
[TBL] [Abstract][Full Text] [Related]
69. Effects of extract of Ginkgo biloba leaves and its constituents on carcinogen-metabolizing enzyme activities and glutathione levels in mouse liver.
Sasaki K; Hatta S; Wada K; Ueda N; Yoshimura T; Endo T; Sakata M; Tanaka T; Haga M
Life Sci; 2002 Feb; 70(14):1657-67. PubMed ID: 11991253
[TBL] [Abstract][Full Text] [Related]
70. Inhibition of human CYP2B6-catalyzed bupropion hydroxylation by Ginkgo biloba extract: effect of terpene trilactones and flavonols.
Lau AJ; Chang TK
Drug Metab Dispos; 2009 Sep; 37(9):1931-7. PubMed ID: 19487249
[TBL] [Abstract][Full Text] [Related]
71. Ginkgo biloba and ovarian cancer prevention: epidemiological and biological evidence.
Ye B; Aponte M; Dai Y; Li L; Ho MC; Vitonis A; Edwards D; Huang TN; Cramer DW
Cancer Lett; 2007 Jun; 251(1):43-52. PubMed ID: 17194528
[TBL] [Abstract][Full Text] [Related]
72. Mechanisms for the vasodilations induced by Ginkgo biloba extract and its main constituent, bilobalide, in rat aorta.
Nishida S; Satoh H
Life Sci; 2003 Apr; 72(23):2659-67. PubMed ID: 12672511
[TBL] [Abstract][Full Text] [Related]
73. Medicinal Values and Potential Risks Evaluation of
Su X; Shi R; Hu H; Hu L; Wei Q; Guan Y; Chang J; Li C
Molecules; 2022 Nov; 27(21):. PubMed ID: 36364306
[TBL] [Abstract][Full Text] [Related]
74. Comparative vasodilating actions among terpenoids and flavonoids contained in Ginkgo biloba extract.
Nishida S; Satoh H
Clin Chim Acta; 2004 Jan; 339(1-2):129-33. PubMed ID: 14687903
[TBL] [Abstract][Full Text] [Related]
75. Activity of Ginkgo biloba extract and quercetin on thrombomodulin expression and tissue-type plasminogen activator secretion by human umbilical vein endothelial cells.
Lan WJ; Zheng XX
Biomed Environ Sci; 2006 Aug; 19(4):249-53. PubMed ID: 17044640
[TBL] [Abstract][Full Text] [Related]
76. Preventive effects of extract of leaves of ginkgo (Ginkgo biloba) and its component bilobalide on azoxymethane-induced colonic aberrant crypt foci in rats.
Suzuki R; Kohno H; Sugie S; Sasaki K; Yoshimura T; Wada K; Tanaka T
Cancer Lett; 2004 Jul; 210(2):159-69. PubMed ID: 15183531
[TBL] [Abstract][Full Text] [Related]
77. [Determination of GA, GB and GC in total lactone of ginkgo (TLG) raw material].
Liu Q; Zhou L
Zhong Yao Cai; 2004 Jan; 27(1):19-20. PubMed ID: 15179783
[TBL] [Abstract][Full Text] [Related]
78. Comparison of phytochemical composition of Ginkgo biloba extracts using a combination of non-targeted and targeted analytical approaches.
Collins BJ; Kerns SP; Aillon K; Mueller G; Rider CV; DeRose EF; London RE; Harnly JM; Waidyanatha S
Anal Bioanal Chem; 2020 Oct; 412(25):6789-6809. PubMed ID: 32865633
[TBL] [Abstract][Full Text] [Related]
79. Ginkgolide B, a constituent of Ginkgo biloba, facilitates glutamate exocytosis from rat hippocampal nerve terminals.
Wang SJ; Chen HH
Eur J Pharmacol; 2005 May; 514(2-3):141-9. PubMed ID: 15910800
[TBL] [Abstract][Full Text] [Related]
80. Inhibition of intestinal and hepatic glucuronidation of mycophenolic acid by Ginkgo biloba extract and flavonoids.
Mohamed MF; Frye RF
Drug Metab Dispos; 2010 Feb; 38(2):270-5. PubMed ID: 19889883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
